Sign in

or Register now

SchizophreniaConnection.com

    See all of our health sites at www.HealthCentral.com
    Thursday, November, 26, 2009
    • Font size
    • Bookmark
    • Save

    All SharePosts Relating To "NAMI"

    EXPERT
    Robin Cunningham

    Robin Cunningham

    (Profile)
    Advocate and Executive
    Our Expert |  Living With It
    Get Widget TooltipGet Widget
    This widget is a small module that you can place on personalized sites (like iGoogle, Facebook, or your blog) and get automatic updates from our experts!       |  RSS
    posted 09/09/2007, comments (0)

    NAMI 2007 Convention: An Interview with Jonathan Stanley

    Johnathan Stanley Jonathan Stanley, J.D., is the Acting Executive Director of the Treatment Advocacy Center (TAC), which is a national nonprofit organization dedicated to eliminating barriers to the timely and effective treatment of severe mental disorders. After the onset of bipolar disorder, he graduated from law school, was a practicing... Read moreChevron
    Read all my posts  | Subscribe | Send Message
    EXPERT
    Robin Cunningham

    Robin Cunningham

    (Profile)
    Advocate and Executive
    Our Expert |  Living With It
    Get Widget TooltipGet Widget
    This widget is a small module that you can place on personalized sites (like iGoogle, Facebook, or your blog) and get automatic updates from our experts!       |  RSS
    posted 08/26/2007, comment (1)

    NAMI 2007 Convention: Interview with E. Fuller Torrey

    E. Fuller Torrey, M.D.  This is number five in a series of blogs made possible by the encouragement and financial support of The HealthCentral Network. All represent interviews with senior officers of NAMI [National Alliance on Mental Illness] or other luminaries that attended the NAMI 2007 annual convention. These interviews cover a... Read moreChevron
    Read all my posts  | Subscribe | Send Message
    EXPERT
    Robin Cunningham

    Robin Cunningham

    (Profile)
    Advocate and Executive
    Our Expert |  Living With It
    Get Widget TooltipGet Widget
    This widget is a small module that you can place on personalized sites (like iGoogle, Facebook, or your blog) and get automatic updates from our experts!       |  RSS
    posted 08/23/2007, comment (1)

    FDA Approves Risperdal for the Treatment of Schizophrenia and Bipolar Disorder in Children

    The approval by the FDA for the use of Risperdal in the treatment of schizophrenia and bipolar disorder in children is a momentous event. The decision was apparently made on the basis of a few very short term studies populated by a small number of subjects, a decision which is most uncharacteristic of the FDA. I have a number of acquaintances... Read moreChevron
    Read all my posts  | Subscribe | Send Message
    EXPERT
    Robin Cunningham

    Robin Cunningham

    (Profile)
    Advocate and Executive
    Our Expert |  Living With It
    Get Widget TooltipGet Widget
    This widget is a small module that you can place on personalized sites (like iGoogle, Facebook, or your blog) and get automatic updates from our experts!       |  RSS
    posted 08/19/2007, comments (0)

    NAMI 2007 Convention: Interview with Lynn Borton

    Lynn Borton  This is number four in a series of seven blogs made possible by the encouragement and financial support of The HealthCentral Network. All represent interviews with senior officers of NAMI [National Alliance on Mental Illness] or other luminaries that attended the NAMI 2007 annual convention. These interviews cover a wide... Read moreChevron
    Read all my posts  | Subscribe | Send Message
    EXPERT
    Robin Cunningham

    Robin Cunningham

    (Profile)
    Advocate and Executive
    Our Expert |  Living With It
    Get Widget TooltipGet Widget
    This widget is a small module that you can place on personalized sites (like iGoogle, Facebook, or your blog) and get automatic updates from our experts!       |  RSS
    posted 08/16/2007, comments (0)

    The FDA / DDMAC Request that Pfizer Discontinue use of an Ad for Geodon for Injection

     I have reviewed materials available to me concerning the recent request by the Division of Drug Marketing, Advertising, and Communications (DDMAC) of the U.S. Food and Drug Administration (FDA) that Pfizer discontinue its use of an ad placed in a professional journal for Geodon (ziprasidone mesylate) for injection. These materials included a... Read moreChevron
    Read all my posts  | Subscribe | Send Message
    • Font size
    • Bookmark
    • Save
    Schizophrenia is a syndrome characterized by disturbances in emotions, thought, activity, and language, that leaves patients fearful and withdrawn.

    Ask a Question

    Get answers from our experts and community members.

    View all questions (902) >
    Related Schizophrenia Topics
    Note: All clinical content on this site is physician-reviewed, except material generated by our community members.
    Non-Profit Affiliates:
    • NAMI
    • NARSAD
    Featuring Content From:
    • Harvard Health Publications
    • A.D.A.M.
    • Thomson PDR
    • Ivanhoe Broadcast News

    By using this service, you accept our Terms of Use. Please read them. The consumer health information on SchizophreniaConnection.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

    This website is accredited by Health On the Net Foundation. Click to verify.We comply with the HONcode standard for trustworthy health information: verify here.
    • TRUSTe Certified Privacy
    • Health Care Standard of Excellence
    • FREDDIE International Health and Medical Media Award Finalist